OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 94 filers reported holding OCULAR THERAPEUTIX INC in Q1 2020. The put-call ratio across all filers is 0.20 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $44 | -99.9% | 15,814 | +19.1% | 0.00% | -20.0% |
| Q3 2022 | $55,000 | -73.9% | 13,274 | -37.0% | 0.01% | -80.0% |
| Q3 2021 | $211,000 | -37.2% | 21,066 | -11.1% | 0.02% | -26.5% |
| Q2 2021 | $336,000 | -1.8% | 23,702 | +13.8% | 0.03% | -12.8% |
| Q1 2021 | $342,000 | +12.5% | 20,828 | -47.9% | 0.04% | -20.4% |
| Q3 2020 | $304,000 | +192.3% | 39,974 | +90.7% | 0.05% | +145.0% |
| Q1 2020 | $104,000 | +23.8% | 20,960 | -0.6% | 0.02% | +33.3% |
| Q4 2018 | $84,000 | -56.9% | 21,077 | +0.1% | 0.02% | -67.4% |
| Q1 2017 | $195,000 | -34.1% | 21,062 | -40.6% | 0.05% | -41.8% |
| Q4 2016 | $296,000 | – | 35,458 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
| Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
| Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
| NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
| Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
| Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
| Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
| BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |